SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950123-05-013752
Filing Date
2005-11-16
Accepted
2005-11-16 16:58:43
Documents
6
Effectiveness Date
2005-11-16

Document Format Files

Seq Description Document Type Size
1 FORM S-8 y14876sv8.htm S-8 70423
2 EX-4.1: STOCK INCENTIVE PLAN y14876exv4w1.htm EX-4.1 34222
3 EX-4.2: STOCK PLAN FOR ASSUMED OPTIONS y14876exv4w2.htm EX-4.2 68335
4 EX-4.3: AMENDED AND RESTATED STOCK INCENTIVE PLAN y14876exv4w3.htm EX-4.3 49709
5 EX-5.1: OPINION OF SAUL EWING LLP y14876exv5w1.htm EX-5.1 4985
6 EX-23.1: CONSENT OF KPMG LLP y14876exv23w1.htm EX-23.1 2905
  Complete submission text file 0000950123-05-013752.txt   232114
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: S-8 | Act: 33 | File No.: 333-129749 | Film No.: 051210402
SIC: 2835 In Vitro & In Vivo Diagnostic Substances